SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3774Recombinant Capital, "in recognition of the skills and accomplishments of tscaram(o)uche3/1/2004
3773money spilling over the sector, flooding the sector, no end in sight.scaram(o)uche3/1/2004
3772Momenta Pharmaceuticals Raises $20.5 Million in Series C Equity Financing CAMBRnigel bates3/1/2004
3771TransMolecular Closes $33.2 Million Series C Financing Monday March 1, 8:30 am Enigel bates3/1/2004
3770Is Biotechnology Losing Its Nerve? By ANDREW POLLACK Published: February 29, 20hmpa2/28/2004
3769igeneon Raises EUR 26.7 Million in a Series C Financing Round Co-Led By Burrill nigel bates2/27/2004
3768Best to you, too, Rick. I'm well on my way to recovering what I lost in 200The Dodgy Ticker2/26/2004
3767Hey!! Who did that?? Best regards, Bob, hearty regards! Rickscaram(o)uche2/26/2004
3766very. this was not the legacy that biotech was meant to have. (eom)scaram(o)uche2/26/2004
3765$4.400/months, this is sad.Miljenko Zuanic2/26/2004
3764FINALLY! BVFL.P. is where it belongs, and not in "Coffeshop." Bravo!The Dodgy Ticker2/26/2004
3763Bravo, bravo, bravo Genentech! <<Food and Drug Administration (FDA) has Miljenko Zuanic2/26/2004
3762BVF holds a large position in GNE puts, right? (thanks, Wilder, George and othescaram(o)uche2/26/2004
3761Joe Kernan is on CNBC right now, talking Genentech, Folkman and market caps.scaram(o)uche2/26/2004
3760As always, there's the question...... differential in market cap between thscaram(o)uche2/26/2004
3759FDA Approves Avastin(TM), a Targeted Therapy for First-Line Metastatic Colorectascaram(o)uche2/26/2004
3758...Merck has purchased $10 million of deCODE common stock at a price of $14.50 pnigel bates2/26/2004
3757BVF is out of amev. Sold their stake after it became obvious a competing bid wasrkrw2/24/2004
3756His nimble ability appears to be serving him quite well. The AMEV position willmopgcw2/24/2004
3755Wow. Traders. Like many, Mark et al. got clobbered, summer '97. Subsequenscaram(o)uche2/24/2004
3754BVF % Value allocation: ACLARA 0.06% AVM 8.43% AMGEN April 45 Pmopgcw2/24/2004
3753BVF Update: First # is Current Shares 2nd #:Change from Last Report ACLARA mopgcw2/24/2004
3752and some don't work out: SuperGen Inc. Announces Intent To Withdraw The Regimopgcw2/24/2004
3751memantine......... Researchers Report Namenda(TM) Provides Significant Benefitsscaram(o)uche2/23/2004
3750cool, drama under our own roof! a link to a post, for others....... Message 19scaram(o)uche2/23/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News